Marketing is not sales , there is always a gray area of how to translate marketing data, analysis into actionable sales programs, here is a short discussion on how to translate marketing data, analysis, into sales programs, in short translating strategic conceptual to actionable plans in sales
If you need a copy of the Power point presentation email your request @ dngrtz2000@hotmail.com, will send you your copy immediately.
The chemical industry in India has evolved significantly since independence in 1947. Some of the earliest chemical factories after independence included Bengal Chemicals in Kolkata, the Sindri fertilizer plant in Rajasthan, and a small petroleum refinery in Assam. Currently, the Indian chemical industry contributes around 3% to India's GDP and 11% of total industrial output. It is also a significant export industry, contributing around 10% of India's total exports. The industry has major segments including inorganic chemicals, drugs and pharmaceuticals, petrochemicals, pesticides, fertilizers, and specialty/fine chemicals. Major players in these segments include companies like Reliance Industries, Haldia Petrochemicals, Ran
The document provides an analysis of the Pakistan pharmaceutical market. Some key points:
- The total Pakistan pharma market is US$2.177 billion and is growing at a CAGR of 10.22% in US dollars.
- The top 11 corporations have reached Rs. 5 billion in sales and account for 49.22% of the market share.
- Top 50 corporations control 86% of the market and top 100 corporations control 95.95% of the market.
- 398 new products were launched in the last 12 months, with 20 from multinational corporations and 378 from national companies.
Marketing is not sales , there is always a gray area of how to translate marketing data, analysis into actionable sales programs, here is a short discussion on how to translate marketing data, analysis, into sales programs, in short translating strategic conceptual to actionable plans in sales
If you need a copy of the Power point presentation email your request @ dngrtz2000@hotmail.com, will send you your copy immediately.
The chemical industry in India has evolved significantly since independence in 1947. Some of the earliest chemical factories after independence included Bengal Chemicals in Kolkata, the Sindri fertilizer plant in Rajasthan, and a small petroleum refinery in Assam. Currently, the Indian chemical industry contributes around 3% to India's GDP and 11% of total industrial output. It is also a significant export industry, contributing around 10% of India's total exports. The industry has major segments including inorganic chemicals, drugs and pharmaceuticals, petrochemicals, pesticides, fertilizers, and specialty/fine chemicals. Major players in these segments include companies like Reliance Industries, Haldia Petrochemicals, Ran
The document provides an analysis of the Pakistan pharmaceutical market. Some key points:
- The total Pakistan pharma market is US$2.177 billion and is growing at a CAGR of 10.22% in US dollars.
- The top 11 corporations have reached Rs. 5 billion in sales and account for 49.22% of the market share.
- Top 50 corporations control 86% of the market and top 100 corporations control 95.95% of the market.
- 398 new products were launched in the last 12 months, with 20 from multinational corporations and 378 from national companies.
Health and fitness apps and devices collect users' personal data, but it is unclear how user data is monetized and who earns from it. A proposed solution is a personal health record platform with an open app store that crowd-sources app development and takes a percentage of app store revenues, while providing platform-level privacy and easy data access. This could form the basis of a new business model for personal health and healthcare data.
This document discusses using ELISA without washing steps by developing a switchable reporter enzyme system. It describes tuning a beta-lactamase enzyme and its inhibitor protein to have high affinity binding and then using this system for wash-free ELISA assays. The goal is to create assays that are faster and require less hands-on time by eliminating washing steps traditionally required in ELISA.
Health and fitness apps and devices collect users' personal data, but it is unclear how user data is monetized and who earns from it. A proposed solution is a personal health record platform with an open app store that crowd-sources app development and takes a percentage of app store revenues, while providing platform-level privacy and easy data access. This could form the basis of a new business model for personal health and healthcare data.
This document discusses using ELISA without washing steps by developing a switchable reporter enzyme system. It describes tuning a beta-lactamase enzyme and its inhibitor protein to have high affinity binding and then using this system for wash-free ELISA assays. The goal is to create assays that are faster and require less hands-on time by eliminating washing steps traditionally required in ELISA.
Jack Schalken has co-founded two companies - NovioGendix in 2006 and Oncodrone in 2013 - to translate his translational research into clinical applications and products. As an "entrepreneurial scientist", he learned important lessons about negotiating terms with his academic institution, building a management team, securing financing, and acquiring business skills to successfully launch and grow these ventures. Both companies have worked to bridge the gap between research and clinical validation or product development for cancer diagnostics and therapeutics.
3. Lead Pharma Innovative Medicine 2 locaties: Nijmegen en Den Bosch 17 medewerkers computermodeling Moleculairebiologie Eiwitchemie Humane cellulaireziektemodellenafkomstig van Stamcellen
4. Wat is Chronisch hartfalen? Eenziektewaarbij het hart langzaamstopt met het rondpompen van het bloed Vitale organenkrijgen minder bloed Oorzaken: Hogebloeddruk Diabetes hartinfarct
5. Chronisch hartfalen Grootste “unmed medical need” Hoeveelmensenhebben de ziekte (prevalentie) Wat is het vooruitzicht (prognose) Wat is eraantedoen (therapie)
6. 1. Chronisch hartfalen - Prevalentie ±100 Miljoen Individuen 20 miljoen Westerse wereld 40 miljoen India en China ±1.2 Miljard Individuen lopen risico Hoge bloeddruk: ± 1000 miljoen - 30% Diabetes: ±200 miljoen - 20% Hartinfarcten: ±50 miljoen - 60% Prevalentie neemt toe door de vergrijzing en toename in lichaamsgewicht
7. 2. Chronisch hartfalen - Prognose Na de diagnose chronisch hartfalen zal binnen 5jaar 70% van patienten overleden zijn
11. Ontwikkeling nieuwe medicijnen Chronischhartfalenkrijgtzeerweiningaandacht van fondsenverstrekkers en farmaceutischebedrijven Erzijnnauwelijksnieuwemedicijnen in ontwikkelingtegenchronischhartfalen Lead Pharma heeftverschillendeveelbelovendenieuwestoffentegenchronsichehartfalen in preklinischeontwikkeling